• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患有非常早发性全身型幼年特发性关节炎的患者表现出更多的炎症特征和更差的预后。

Patients with very early-onset systemic juvenile idiopathic arthritis exhibit more inflammatory features and a worse outcome.

机构信息

Service of Immunology and Rheumatology, Hospital de Pediatría Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina.

出版信息

J Rheumatol. 2013 Mar;40(3):329-34. doi: 10.3899/jrheum.120386. Epub 2013 Jan 15.

DOI:10.3899/jrheum.120386
PMID:23322471
Abstract

OBJECTIVE

Systemic juvenile idiopathic arthritis (SJIA) frequently leads to disability and damage. Predictive factors for a poor outcome include persistent systemic features and younger age at onset. We describe and analyze disease features in patients with early-onset (EO) SJIA (disease onset before age 18 mo) and compare them to patients with later-onset (LO) disease.

METHODS

Clinical features at onset, activity measures (occurrence of macrophage activation syndrome, remission), and outcome measures for disability [Childhood Health Assessment Questionnaire (CHAQ) ≥ 0.5] and damage [radiographic joint destruction, Juvenile Arthritis Damage Index (JADI) score, growth retardation] observed during followup were analyzed retrospectively in patients with SJIA followed for ≥ 3 years since disease onset.

RESULTS

In total 132 patients were included. SJIA started at age ≤ 18 months in 19 (14%) patients and at a later age in 113 (86%) children. At onset, serositis (p < 0.01) and hepatomegaly (p < 0.05) were more frequent in EO patients, who also exhibited lower hemoglobin levels (p < 0.03) and higher platelet counts (p < 0.03) than patients with LO. Macrophage activation syndrome occurred in 20 patients (11 EO and 9 LO; p < 0.0001). Remission was achieved by 49 patients (37%; 4 EO and 45 LO). At last visit, destructive hip disease (p < 0.04), growth retardation (p < 0.01), radiographic damage (p < 0.02), and disability (p < 0.04) were more frequent in patients with EO disease, who had higher JADI scores (p < 0.003).

CONCLUSION

Patients with EO exhibited a more aggressive and destructive disease course than patients with LO SJIA.

摘要

目的

全身性幼年特发性关节炎(SJIA)常导致残疾和损伤。预后不良的预测因素包括持续的全身表现和发病年龄较小。我们描述和分析了早发性(EO)SJIA(发病年龄在 18 个月之前)患者的疾病特征,并将其与晚发性(LO)疾病患者进行了比较。

方法

回顾性分析了 132 例 SJIA 患者的临床特征(发病时、活动指标[巨噬细胞活化综合征的发生、缓解])和随访期间的残疾[儿童健康评估问卷(CHAQ)≥0.5]和损伤[关节放射学破坏、幼年关节炎损伤指数(JADI)评分、生长迟缓]的指标。所有患者的 SJIA 发病时间均≥3 年。

结果

共纳入 132 例患者。19 例(14%)患者 SJIA 发病年龄≤18 个月,113 例(86%)患儿发病年龄较晚。发病时,EO 患者出现浆膜炎(p<0.01)和肝肿大(p<0.05)的频率更高,且血红蛋白水平较低(p<0.03)、血小板计数较高(p<0.03)。20 例患者(11 例 EO 和 9 例 LO;p<0.0001)发生巨噬细胞活化综合征。49 例患者(37%;4 例 EO 和 45 例 LO)达到缓解。末次随访时,EO 患者破坏性髋关节疾病(p<0.04)、生长迟缓(p<0.01)、放射学损伤(p<0.02)和残疾(p<0.04)的频率更高,JADI 评分更高(p<0.003)。

结论

EO 患者的疾病病程较 LO SJIA 患者更具侵袭性和破坏性。

相似文献

1
Patients with very early-onset systemic juvenile idiopathic arthritis exhibit more inflammatory features and a worse outcome.患有非常早发性全身型幼年特发性关节炎的患者表现出更多的炎症特征和更差的预后。
J Rheumatol. 2013 Mar;40(3):329-34. doi: 10.3899/jrheum.120386. Epub 2013 Jan 15.
2
Analysis of disease activity, functional disability and articular damage in patients with juvenile idiopathic arthritis: a prospective outcome study.幼年特发性关节炎患者的疾病活动度、功能障碍和关节损伤分析:一项前瞻性结局研究。
Clin Exp Rheumatol. 2011 Mar-Apr;29(2):337-44. Epub 2011 Apr 19.
3
Clinical profile and juvenile arthritis damage index in children with juvenile idiopathic arthritis: A study from a tertiary care center in south India.儿童特发性关节炎患儿的临床特征与幼年关节炎损伤指数:来自印度南部一家三级护理中心的研究
Int J Rheum Dis. 2018 Apr;21(4):871-879. doi: 10.1111/1756-185X.12886. Epub 2016 Jun 16.
4
Predictors of hip disease in the systemic arthritis subtype of juvenile idiopathic arthritis.预测幼年特发性关节炎全身型亚类的髋关节疾病。
J Rheumatol. 2011 May;38(5):954-8. doi: 10.3899/jrheum.101146. Epub 2011 Feb 1.
5
Radiologic outcome and its relationship to functional disability in juvenile rheumatoid arthritis.幼年型类风湿关节炎的放射学结果及其与功能残疾的关系。
J Rheumatol. 2003 Apr;30(4):832-40.
6
Discrepancy between clinical and radiological responses to tocilizumab treatment in patients with systemic-onset juvenile idiopathic arthritis.全身型幼年特发性关节炎患者托珠单抗治疗的临床反应与放射学反应之间的差异。
J Rheumatol. 2014 Jun;41(6):1171-7. doi: 10.3899/jrheum.130924. Epub 2014 May 1.
7
Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus.系统性幼年特发性关节炎和系统性红斑狼疮患儿的巨噬细胞活化综合征
Rheumatol Int. 2016 Oct;36(10):1421-9. doi: 10.1007/s00296-016-3545-9. Epub 2016 Aug 10.
8
The Systemic Juvenile Idiopathic Arthritis Cohort of the Childhood Arthritis and Rheumatology Research Alliance Registry: 2010-2013.儿童关节炎与风湿病研究联盟登记处的系统性幼年特发性关节炎队列研究:2010 - 2013年
J Rheumatol. 2016 Sep;43(9):1755-62. doi: 10.3899/jrheum.150997. Epub 2016 Jun 15.
9
Dissecting the heterogeneity of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.剖析并发系统性幼年特发性关节炎的巨噬细胞活化综合征的异质性。
J Rheumatol. 2015 Jun;42(6):994-1001. doi: 10.3899/jrheum.141261. Epub 2015 Apr 15.
10
Predictors of disease course in systemic juvenile idiopathic arthritis.系统性幼年特发性关节炎疾病进程的预测因素。
Mod Rheumatol. 2024 Oct 15;34(6):1238-1245. doi: 10.1093/mr/roae036.

引用本文的文献

1
EULAR/PReS recommendations for the diagnosis and management of Still's disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still's disease.EULAR/PReS 关于斯蒂尔病(包括全身型幼年特发性关节炎和成人斯蒂尔病)的诊断和治疗建议。
Ann Rheum Dis. 2024 Nov 14;83(12):1614-1627. doi: 10.1136/ard-2024-225851.
2
Systemic juvenile idiopathic arthritis and adult-onset Still's disease are the same disease: evidence from systematic reviews and meta-analyses informing the 2023 EULAR/PReS recommendations for the diagnosis and management of Still's disease.系统性幼年特发性关节炎和成人斯蒂尔病是同一种疾病:来自系统评价和荟萃分析的证据,为 2023 年 EULAR/PReS 斯蒂尔病诊断和管理建议提供信息。
Ann Rheum Dis. 2024 Nov 14;83(12):1748-1761. doi: 10.1136/ard-2024-225853.
3
Interleukin (IL)-1/IL-6-Inhibitor-Associated Drug Reaction With Eosinophilia and Systemic Symptoms (DReSS) in Systemic Inflammatory Illnesses.白细胞介素 (IL)-1/IL-6 抑制剂相关嗜酸性粒细胞增多和全身症状药物反应 (DReSS) 在炎症性疾病中的作用。
J Allergy Clin Immunol Pract. 2024 Nov;12(11):2996-3013.e7. doi: 10.1016/j.jaip.2024.07.002. Epub 2024 Aug 15.
4
The 4th NextGen Therapies for SJIA and MAS: part 1 the elephant in the room: diagnostic/classification criteria for systemic juvenile idiopathic arthritis and adult-onset still's disease.第 4 次用于 SJIA 和 MAS 的下一代治疗方法:第 1 部分:房间里的大象:全身型幼年特发性关节炎和成人斯蒂尔病的诊断/分类标准。
Pediatr Rheumatol Online J. 2024 Jan 5;21(Suppl 1):114. doi: 10.1186/s12969-023-00864-1.
5
The childhood arthritis radiographic score of the hip: the proposal cut-off value using cluster analysis.髋关节幼年特发性关节炎放射学评分:使用聚类分析的建议截断值。
Clin Rheumatol. 2024 Jan;43(1):465-472. doi: 10.1007/s10067-023-06749-8. Epub 2023 Aug 28.
6
Implications of Evolving Disease Classification for Drug Approval in Juvenile Idiopathic Arthritis.不断演变的疾病分类对幼年特发性关节炎药物审批的影响。
Paediatr Drugs. 2022 May;24(3):185-191. doi: 10.1007/s40272-022-00496-0. Epub 2022 Apr 1.
7
Identification of Key Biomarkers and Immune Infiltration in Systemic Juvenile Idiopathic Arthritis by Integrated Bioinformatic Analysis.通过综合生物信息学分析鉴定全身型幼年特发性关节炎的关键生物标志物和免疫浸润
Front Mol Biosci. 2021 Jul 14;8:681526. doi: 10.3389/fmolb.2021.681526. eCollection 2021.
8
Biological classification of childhood arthritis: roadmap to a molecular nomenclature.儿童关节炎的生物学分类:迈向分子命名法的蓝图。
Nat Rev Rheumatol. 2021 May;17(5):257-269. doi: 10.1038/s41584-021-00590-6. Epub 2021 Mar 17.
9
Clinical variability of the systemic juvenile idiopathic arthritis course: literature review based on case series.系统性幼年特发性关节炎病程的临床变异性:基于病例系列的文献综述
Reumatologia. 2020;58(6):436-443. doi: 10.5114/reum.2020.102010. Epub 2020 Dec 23.
10
Imaging assessment of children presenting with suspected or known juvenile idiopathic arthritis: ESSR-ESPR points to consider.疑似或已知幼年特发性关节炎患儿的影像学评估:ESSR-ESPR 需考虑要点。
Eur Radiol. 2020 Oct;30(10):5237-5249. doi: 10.1007/s00330-020-06807-8. Epub 2020 May 12.